We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
116 hedge funds and large institutions have $90M invested in Puma Biotechnology in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,680% more call options, than puts
Call options by funds: $178K | Put options by funds: $10K
76% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 25
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
4% more funds holding
Funds holding: 112 → 116 (+4)
1.43% more ownership
Funds ownership: 59.88% → 61.31% (+1.4%)
0% more capital invested
Capital invested by funds: $89.7M → $90M (+$370K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
116
Holders Change
+4
Holders Change %
+3.57%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
44
Reduced
25
Closed
20
Calls
$178K
Puts
$10K
Net Calls
+$168K
Net Calls Change
+$47K
Top Buyers
Top Sellers
| 1 |
EP
Eversept Partners
New York
|
-$2.25M |
| 2 |
Millennium Management
New York
|
-$1.59M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$499K |
| 4 |
JP Morgan Chase
New York
|
-$277K |
| 5 |
Squarepoint
New York
|
-$232K |
